SUBLICENSE AGREEMENTSublicense Agreement • August 19th, 2016 • Checkpoint Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS SUBLICENSE AGREEMENT (the “Agreement”) is dated as of May 26, 2016 (the “Effective Date”) by and between Checkpoint Therapeutics, Inc, a Delaware corporation with its place of business at 2 Gansevoort Street, 9th Floor, New York, New York 10014 (“Checkpoint”), and TG Therapeutics, Inc, Inc., a Delaware corporation with its place of business at 2 Gansevoort Street, 9th Floor, New York, New York 10014 (“TGTX”). Checkpoint, on the one hand, and TGTX, on the other hand, shall each be referred to herein as a “Party” or, collectively, as the “Parties.”
ASSIGNMENT AND ASSUMPTION AGREEMENTAssignment and Assumption Agreement • August 19th, 2016 • Checkpoint Therapeutics, Inc. • Pharmaceutical preparations
THIS ASSIGNMENT AND ASSUMPTION AGREEMENT ("Assignment and Assumption Agreement") is and effective March 17, 2015, by and between by and between Fortress Biotech., Inc., a Delaware corporation ("Fortress") and Checkpoint Therapeutics, Inc., a Delaware corporation ("Checkpoint").
ASSIGNMENT AND ASSUMPTION AGREEMENTAssignment and Assumption Agreement • August 19th, 2016 • Checkpoint Therapeutics, Inc. • Pharmaceutical preparations
THIS ASSIGNMENT AND ASSUMPTION AGREEMENT (“Assignment and Assumption Agreement”) is effective March 17, 2015 (the “Effective Date”), by and between Fortress Biotech, Inc. (“Fortress”), a Delaware corporation, and Checkpoint Therapeutics, Inc. (“Checkpoint”), a Delaware corporation.
